Financial Counselors Inc’s GSK GSK Stock Holding History

Financial Counselors Inc’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-135,437	Closed	-$5.25M	–	225
2025 Q1	$5.25M	Sell	135,437 -6,823	-5%	-$250K	0.08%	191
2024 Q4	$4.81M	Sell	142,260 -2,915	-2%	-$105K	0.07%	199
2024 Q3	$5.93M	Sell	145,175 -3,055	-2%	-$125K	0.09%	182
2024 Q2	$5.71M	Sell	148,230 -3,991	-3%	-$168K	0.09%	179
2024 Q1	$6.53M	Sell	152,221 -1,164	-0.8%	-$48K	0.11%	167
2023 Q4	$5.68M	Buy	153,385 +3,750	+3%	+$135K	0.1%	175
2023 Q3	$5.42M	Sell	149,635 -999	-0.7%	-$35.5K	0.11%	169
2023 Q2	$5.37M	Sell	150,634 -5,779	-4%	-$207K	0.11%	168
2023 Q1	$5.57M	Sell	156,413 -2,689	-2%	-$94.1K	0.12%	162
2022 Q4	$5.59M	Sell	159,102 -804	-0.5%	-$26.8K	0.13%	163
2022 Q3	$4.71M	Sell	159,906 -12,628	-7%	-$479K	0.12%	166
2022 Q2	$9.39M	Sell	172,534 -232	-0.1%	-$12.8K	0.22%	121
2022 Q1	$9.41M	Sell	172,766 -86,599	-33%	-$4.7M	0.19%	131
2021 Q4	$14.3M	Buy	259,365 +1,502	+0.6%	+$78.1K	0.29%	99
2021 Q3	$12.3M	Buy	257,863 +1,757	+0.7%	+$88.3K	0.26%	112
2021 Q2	$12.7M	Sell	256,106 -4,827	-2%	-$232K	0.28%	104
2021 Q1	$11.6M	Buy	260,933 +4,391	+2%	+$199K	0.27%	109
2020 Q4	$11.8M	Sell	256,542 -1,165	-0.5%	-$53.5K	0.3%	98
2020 Q3	$12.1M	Buy	257,707 +1,253	+0.5%	+$62.8K	0.36%	85
2020 Q2	$13.1M	Buy	256,454 +10,761	+4%	+$552K	0.42%	69
2020 Q1	$11.6M	Sell	245,693 -4,577	-2%	-$244K	0.52%	55
2019 Q4	$14.7M	Sell	250,270 -360	-0.1%	-$20K	0.52%	60
2019 Q3	$13.4M	Buy	250,630 +3,986	+2%	+$205K	0.53%	57
2019 Q2	$12.3M	Buy	246,644 +3,942	+2%	+$198K	0.5%	59
2019 Q1	$12.7M	Buy	242,702 +9,880	+4%	+$494K	0.54%	57
2018 Q4	$11.1M	Buy	232,822 +37,219	+19%	+$1.83M	0.55%	53
2018 Q3	$9.82M	Sell	195,603 -3,352	-2%	-$170K	0.43%	79
2018 Q2	$10M	Buy	198,955 +3,940	+2%	+$198K	0.46%	68
2018 Q1	$9.52M	Buy	195,015 +35,749	+22%	+$1.66M	0.45%	68
2017 Q4	$7.06M	Buy	159,266 +15,657	+11%	+$723K	0.32%	106
2017 Q3	$7.29M	Buy	143,609 +250	+0.2%	+$12.7K	0.36%	91
2017 Q2	$7.73M	Sell	143,359 -411	-0.3%	-$21.9K	0.38%	90
2017 Q1	$7.58M	Buy	143,770 +4,500	+3%	+$228K	0.39%	86
2016 Q4	$6.7M	Buy	+139,270	New	+$6.88M	0.36%	96
2016 Q2	$7.69M	Buy	141,865 +4,495	+3%	+$237K	0.46%	74
2016 Q1	$6.96M	Sell	137,370 -3,216	-2%	-$160K	0.43%	78
2015 Q4	$7.09M	Sell	140,586 -6,540	-4%	-$333K	0.46%	70
2015 Q3	$7.07M	Sell	147,126 -2,578	-2%	-$134K	0.49%	66
2015 Q2	$7.79M	Buy	149,704 +12,333	+9%	+$694K	0.5%	61
2015 Q1	$7.92M	Sell	137,371 -1,715	-1%	-$98.3K	0.49%	64
2014 Q4	$7.43M	Buy	139,086 +1,717	+1%	+$96.1K	0.47%	67
2014 Q3	$7.89M	Buy	137,369 +1,955	+1%	+$120K	0.55%	49
2014 Q2	$9.05M	Sell	135,414 -23,644	-15%	-$1.6M	0.63%	43
2014 Q1	$10.6M	Sell	159,058 -9,191	-5%	-$621K	0.76%	27
2013 Q4	$11.2M	Buy	168,249 +7,359	+5%	+$477K	0.84%	29
2013 Q3	$10.1M	Sell	160,890 -5,749	-3%	-$370K	0.83%	31
2013 Q2	$10.4M	Buy	+166,639	New	+$10.6M	0.86%	30

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Financial Counselors Inc's GSK Position: Q2 2025 in Review

Financial Counselors Inc sold out of GSK (GSK) in Q2 2025, closing a stake of 135,437 shares — an estimated $5.25M sold.

Financial Counselors Inc first reported a position in GSK in Q2 2013 and held it in 47 quarters. The position peaked at $14.7M in Q4 2019. 891 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

Financial Counselors Inc reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
Financial Counselors Inc sold 135,437 GSK shares in Q2 2025, an estimated $5.25M.
Financial Counselors Inc first reported a position in GSK in Q2 2013 and held it in 47 quarters.
Financial Counselors Inc's GSK position peaked at $14.7M in Q4 2019.
891 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.